NASDAQ:SGRY - Nasdaq - US86881A1007 - Common Stock - Currency: USD
SURGERY PARTNERS INC
NASDAQ:SGRY (2/4/2025, 8:07:27 PM)
After market: 25.7 0 (0%)25.7
+0.4 (+1.58%)
The current stock price of SGRY is 25.7 USD. In the past month the price increased by 21.92%. In the past year, price decreased by -23.74%.
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners experiencing significant growth due to strategic developments.
BRENTWOOD, Tenn., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay...
BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that Dr....
BRENTWOOD, Tenn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (
BRENTWOOD, Tenn., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 15.14 | 84.80B | ||
BKDT | BROOKDALE SENIOR LIVING - BKD 7 11/15/25 | N/A | 13.68B | ||
THC | TENET HEALTHCARE CORP | 12.9 | 13.67B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 12.97 | 12.71B | ||
EHC | ENCOMPASS HEALTH CORP | 24.03 | 10.19B | ||
ENSG | ENSIGN GROUP INC/THE | 27.48 | 8.33B | ||
ACHC | ACADIA HEALTHCARE CO INC | 12.84 | 4.19B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 8.8 | 2.99B | ||
SEM | SELECT MEDICAL HOLDINGS CORP | 9.43 | 2.60B | ||
PACS | PACS GROUP INC | 18.86 | 2.22B | ||
ARDT | ARDENT HEALTH PARTNERS INC | 40.03 | 2.17B | ||
NHC | NATIONAL HEALTHCARE CORP | 12.74 | 1.57B |
Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. The company is headquartered in Brentwood, Tennessee and currently employs 10,500 full-time employees. The company went IPO on 2015-10-01. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. Its segments include Surgical Facility Services and Ancillary Services. The Surgical Facility Services segment consists of the operation of ASCs and surgical hospitals and includes its anesthesia services. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology and general surgery. The Ancillary Services segment consisted of multi-specialty physician practices, including physician practices owned and operated pursuant to long-term management service agreements. The company is focused on surgical services businesses in the United States, with over 180 locations in 33 states, including ambulatory surgery centers, short-stay surgical hospitals, and multi-specialty physician practices.
SURGERY PARTNERS INC
310 Seven Springs Way Ste 500
Brentwood TENNESSEE 37027 US
CEO: J. Eric Evans
Employees: 10500
Company Website: https://surgerypartners.com/
Investor Relations: https://ir.surgerypartners.com/
Phone: 16152345900
The current stock price of SGRY is 25.7 USD.
The exchange symbol of SURGERY PARTNERS INC is SGRY and it is listed on the Nasdaq exchange.
SGRY stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for SGRY, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of SGRY.
SGRY does not pay a dividend.
The PE ratio for SGRY is 27.34. This is based on the reported non-GAAP earnings per share of 0.94 and the current share price of 25.7 USD.
The outstanding short interest for SGRY is 13.94% of its float.
ChartMill assigns a technical rating of 5 / 10 to SGRY. When comparing the yearly performance of all stocks, SGRY is a bad performer in the overall market: 85.9% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to SGRY. There are concerns on the financial health of SGRY while its profitability can be described as average.
Over the last trailing twelve months SGRY reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS increased by 14.63% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -0.8% | ||
ROE | -3.2% | ||
Debt/Equity | 1.63 |
ChartMill assigns a Buy % Consensus number of 80% to SGRY. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of -10.76% and a revenue growth 11.94% for SGRY